These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17378075)

  • 1. Late blood clots tarnish drug-coated stents. Uncommon complication raises questions about who really needs a drug-coated stent and how long to continue drug therapy after getting one.
    Harv Heart Lett; 2007 Mar; 17(7):4-5. PubMed ID: 17378075
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug-eluting stents can increase the risk of late stent thrombosis].
    Skyttberg N; Linder R; Carlsson J
    Lakartidningen; 2006 Sep 27-Oct 3; 103(39):2845-7. PubMed ID: 17128916
    [No Abstract]   [Full Text] [Related]  

  • 3. [How does it work? Coronary stent implantation].
    Rampp T; Block M
    MMW Fortschr Med; 2004 Jun; 146(23):64-5. PubMed ID: 15373140
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood clots a late hazard for drug-coated stents. The benefits of drug-coated stents come with a price--long term use of clot-preventing drugs.
    Harv Heart Lett; 2006 Aug; 16(12):1-3. PubMed ID: 16918032
    [No Abstract]   [Full Text] [Related]  

  • 5. [What should one pay attention to during surgery shortly after brachytherapy with coated stents?].
    Schneider C
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1586. PubMed ID: 15243911
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should EDTA chelation therapy be used instead of long-term clopidogrel plus aspirin to treat patients at risk from drug-eluting stents?
    Chappell LT
    Altern Med Rev; 2007 Jun; 12(2):152-8. PubMed ID: 17604460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
    Jähne J; Schirren J
    Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug-releasing stents. Little use in cardiology despite excellent data--what next?].
    Schneider H; Weber F; Nienaber CA
    Dtsch Med Wochenschr; 2006 May; 131(21):1235-6; author reply 1236. PubMed ID: 16721715
    [No Abstract]   [Full Text] [Related]  

  • 10. Which patients receiving warfarin can be treated safely with a drug-eluting stent?
    Ryding AD; Banning AP
    Heart; 2008 Mar; 94(3):275-7. PubMed ID: 18276815
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug eluting stents.
    Gershlick AH; Richardson G
    BMJ; 2006 Dec; 333(7581):1233-4. PubMed ID: 17170395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clarification of patients at risk from the use of laminated stents].
    Kramer HJ
    Dtsch Med Wochenschr; 2006 Jan; 131(1-2):41. PubMed ID: 16374743
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on dual antiplatelet therapy for percutaneous coronary intervention.
    Prasad A; Holmes DR
    Heart; 2009 Jun; 95(11):861-5. PubMed ID: 19372090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary stents and noncardiac surgery.
    Riddell JW; Chiche L; Plaud B; Hamon M
    Circulation; 2007 Oct; 116(16):e378-82. PubMed ID: 17938292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.